Nachrichten

Skript "Antimüllerian Hormone (AMH)" verfasst von Prof. Dr. med. Lutz Tharandt  

06 August, 2019

Der renommierte Endokrinologe Prof. Dr. Lutz Tharandt hat speziell für Sie ein Skript zum Thema "Antimüllerian Hormone (AMH)" erstellt. Das Skript beinhaltet folgende Themen:   Sie können das Skript zum Preis von 25,00 € zzgl. MwSt. in Papierform oder als PDF-Datei erwerben....

z.B. 08/23/2019
z.B. 08/23/2019

bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical

05 April, 2018

Marcy l’Étoile, France – April 4th, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers. In particular, Astute developed the NEPHROCHECK® test, an FDA-cleared test for the early risk assessment of acute kidney injuries (AKI) based on the level of two biomarkers, IGFBP-7 (Insulin-like Growth Factor-Binding Protein-7) and TIMP-2 (Tissue Inhibitor Metalloproteinases-2).

Pioneering diagnostics